Hyperparathyroidism, Secondary
Information
- Disease name
- Hyperparathyroidism, Secondary
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02464072 | Active, not recruiting | N/A | Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under Dialysis | July 2012 | January 2024 |
| NCT00397475 | Completed | N/A | Evaluation of Colecalciferol Substitution in Dialysis Patients | November 2006 | March 2007 |
| NCT00528788 | Completed | Phase 4 | How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis | September 2007 | August 2012 |
| NCT00587158 | Completed | N/A | Oral Paricalcitol in Kidney Transplant Recipients | January 2007 | November 2011 |
| NCT00995163 | Completed | Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease | January 2008 | January 2011 | |
| NCT01134549 | Completed | Phase 1 | Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers | June 9, 2010 | July 31, 2010 |
| NCT01134562 | Completed | Phase 1 | Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism | September 7, 2010 | April 2, 2011 |
| NCT01181531 | Completed | Phase 4 | Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis | October 1, 2010 | August 14, 2012 |
| NCT05382988 | Completed | Phase 3 | Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy | November 2016 | December 2021 |
| NCT02274623 | Completed | Phase 1 | Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid | December 2014 | March 17, 2017 |
| NCT02282813 | Completed | Phase 3 | Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | April 2013 | May 2015 |
| NCT02523209 | Completed | Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation | September 2014 | April 2017 | |
| NCT02830789 | Completed | N/A | Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric Bypass | December 2016 | May 2017 |
| NCT05347082 | Completed | N/A | Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment | April 29, 2021 | February 20, 2022 |
| NCT00211939 | Completed | Phase 4 | CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients | January 2005 | March 2007 |
| NCT01290029 | Completed | Phase 1 | Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease | January 25, 2011 | September 23, 2015 |
| NCT01651000 | Completed | Phase 3 | Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | September 2012 | July 2014 |
| NCT01704079 | Completed | Phase 3 | Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | November 2012 | September 2014 |
| NCT01785849 | Completed | Phase 3 | Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis | March 12, 2013 | June 12, 2014 |
| NCT01785875 | Completed | Phase 3 | Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis | July 31, 2013 | July 1, 2015 |
| NCT01788046 | Completed | Phase 3 | Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis | March 12, 2013 | May 9, 2014 |
| NCT01922843 | Completed | Phase 2 | A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis | September 2013 | June 2014 |
| NCT01932970 | Completed | Phase 3 | Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide | August 12, 2013 | February 14, 2017 |
| NCT02056730 | Completed | Phase 4 | The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid | November 2013 | February 2015 |
| NCT02102204 | Completed | Phase 3 | Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis | March 25, 2014 | June 26, 2017 |
| NCT01277510 | Terminated | Phase 3 | Pediatric Chronic Kidney Disease Safety and Efficacy | June 28, 2011 | |
| NCT01439867 | Terminated | Phase 2 | Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism | June 22, 2012 | June 3, 2016 |
| NCT00646282 | Terminated | Phase 4 | Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients | April 2008 | January 2010 |
| NCT04126954 | Unknown status | Study on the Use of Cinacalcet in Phosphocalcic Context. | January 2020 | December 2023 | |
| NCT02273570 | Unknown status | N/A | Optimal Anemia Treatment in End Stage Renal Disease (ERSD) | March 2015 | March 2017 |
| NCT03063190 | Withdrawn | Phase 4 | Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease | March 31, 2022 | March 2023 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006962